ImageVerifierCode 换一换
格式:PPT , 页数:51 ,大小:218KB ,
文档编号:4998102      下载积分:28 文币
快捷下载
登录下载
邮箱/手机:
温馨提示:
系统将以此处填写的邮箱或者手机号生成账号和密码,方便再次下载。 如填写123,账号和密码都是123。
支付方式: 支付宝    微信支付   
验证码:   换一换

优惠套餐
 

温馨提示:若手机下载失败,请复制以下地址【https://www.163wenku.com/d-4998102.html】到电脑浏览器->登陆(账号密码均为手机号或邮箱;不要扫码登陆)->重新下载(不再收费)。

已注册用户请登录:
账号:
密码:
验证码:   换一换
  忘记密码?
三方登录: 微信登录  
下载须知

1: 试题类文档的标题没说有答案,则无答案;主观题也可能无答案。PPT的音视频可能无法播放。 请谨慎下单,一旦售出,概不退换。
2: 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。
3: 本文为用户(晟晟文业)主动上传,所有收益归该用户。163文库仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对上载内容本身不做任何修改或编辑。 若此文所含内容侵犯了您的版权或隐私,请立即通知163文库(点击联系客服),我们立即给予删除!。
4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
5. 本站仅提供交流平台,并不能对任何下载内容负责。
6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。

版权提示 | 免责声明

1,本文((抗生素教学讲解课件)Introduction-for-Antibiotics.ppt)为本站会员(晟晟文业)主动上传,163文库仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对上载内容本身不做任何修改或编辑。
2,用户下载本文档,所消耗的文币(积分)将全额增加到上传者的账号。
3, 若此文所含内容侵犯了您的版权或隐私,请立即通知163文库(发送邮件至3464097650@qq.com或直接QQ联系客服),我们立即给予删除!

(抗生素教学讲解课件)Introduction-for-Antibiotics.ppt

1、Introduction for Antibiotics R3 孔祥琪孔祥琪Last revised:July 6,2003Section of Infectious DiseasesDepartment of Internal Medicine National Taiwan University Hospital,Taipei臨床上常見的致病微生物 Bacteria Viruses Fungi Mycobacterium Mycoplasma Protozoa臨床上常見的致病菌nAerobicnGram-positive bacterianGram-negative bacterianAn

2、aerobicnGram-positive bacterianGram-negative bacteriaAerobic Gram-positive bacterianCoccinStaphylococcus spp.nStreptococcus spp.nEnterococcus spp.nBacillinListeria spp.nBacillus spp.StaphylococcinCoagulase-positivenStaphylococcus aureusnCoagulase-negativenStaphylococcus epidermidisnStaphylococcus sa

3、prophyticusnStaphylococcus haemolyticusnMethicillin-resistantnMRSAnMRCNSnMethicillin-sensitivenMSSAnMSCNSStreptococci(1)Classification Lancefield:based on the antigenic characteristics of the outer membrane Brown:type of hemolysis Clinical:combines Lancefield,Brown,disease producing charactersticsSt

4、reptococci(2)nalpha hemolysisincomplete hemolysisS.viridans and S.pneumoniaenbeta hemolysiscomplete hemolysisGroup A Strep =S.pyogenesnGamma hemolysisnonhemolyticSome Group D Strep.nS.pyogenes(Group A,hemolytic)Pharyngitis ImpetigonViridans group(alpha hemolytic)EndocarditisnS.pneumoniae(Pneumococcu

5、s)Bacteremia Pneumonia MeningitisGram-positive bacillinBacillus cereusnDiptheroids Corynebacterium diptheriae JK group Corynebacterium Listeria monocytogenesAerobic Gram-negative bacterianBacillinEnterobacteriaceaenNFGNB:Glucose Non-fermentative Gram-negative bacillinHaemophilus species(H.influenzae

6、;H.parainfluenzae)nLegionella pneumophilia nCoccinNeisseria gonorrhoeae(gonococcus)nNeisseria meningitidis(meningococcus)nMoraxella catarrhalis Gram-negative bacteriaEnterobacteriaceaeE.coliKlebsiella spp.Proteus spp.Salmonella spp.Shigella spp.Enterobacter spp.Citrobacter spp.Serratia spp.Edwardsie

7、lla spp.Yersinia spp.NFGNB Pseudomonas aeruginosaAcinetobacter baumanniiStenotrophomonas maltophilia (Pseudomonas maltophilia)Burkholderia cepacia(Pseudomonas cepacia)Anaerobic bacterianGram-positivenCoccinStreptococcus,GemellanPeptococcus,PeptostreptocuccusnBacillinClostridium(C.perfringes,C.tenani

8、,C.difficile,C.botulinum)nPropionibacteriumnBifidobacteriumnLactobacillusnGram-negativenBacillinFusobacteriumnBacteroides nPrevotellanCampylobacter nCocci臨床上常見的致病菌nGram-positive bacterianStaphylococcus aureus nStreptococcusnEnterococcusnGram-negative bacterianE.coli,Klebsiella,Proteus(EKP)nEnterobac

9、ter,SerratianNon-fermentative Gram-negative bacilli(NFGNB)nHaemophilus influenzaenMeningococcusnAnaerobic bacterianBacteroides fragilisnOthers-Lactam antibioticsnPenicillinnCephemnCephalosporinnCephamycinnMonobactamnCarbapenemn-lactam/-lactamase inhibitorPenicillinsnNatural penicillinsnPenicillin G(

10、IV)nPenicillin V(oral)nPenicillinase-resistant penicillinsnOxacillin(IV),MethicillinnDicloxacillin(oral)nBroad-spectrum penicillinsnAmpicillin(IV,oral)nAmoxicillin(oral)nExtended-spectrum penicillinsnCarbenicillin(IV,oral)nTicarcillin(IV)nPiperacillin(IV)Natural PcPcnase-RBroad PcExtended PcGram(+)S

11、taph MSSA -+-MRSA -Streptococcus +Enterococcus +-+Gram(-)E.coli,Kleb -+Enterobacter -+Pseudomonas -+Haemophilus -+(-)Anaerobic Bacteroides -lactam/-lactamase inhibitorsnClinically usednClavulanic acidnSulbactamnTazobactamnSpecial notesnNo antibacterial activitynNever used alone-lactam+-lactamase inh

12、ibitorAmpicillin+Sulbactam =UnasynAmoxicillin+Clavulanic acid =AugmentinTicarcillin+Clavulanic acid =TimentinPiperacillin+Tazobactam =TazocinAmpicillinUnasynAmoxicillinAugmentinGram(+)Staph MSSA -+MRSA -Streptococcus +Enterococcus +Gram(-)E.coli,Kleb +(-)+Enterobacter -Pseudomonas -Haemophilus -+Ana

13、erobic Bacteroides -+TicarcillinTimentinPiperacillinTazocinGram(+)Staph MSSA -+MRSA -Streptococcus +Enterococcus +Gram(-)E.coli,Kleb +(-)+Enterobacter +Pseudomonas +(-)+(-)Haemophilus +(-)+Anaerobic Bacteroides -+CephemsnFirst-generation cephemnCefazolin(IV),Cephalexin(oral)nSecond-generation cephem

14、nAbove diaphragm:Cefuroxime(IV,oral),Cefotiam(IV)nBelow diaphragm:Cefoxitin,cefmetazole(IV cephamycin)nThird-generation cephemnWithout antipseudomonal activitynWith antipseudomonal activitynFourth-generation cephemnCefepime,CefpiromeFirst-generation cephemsnCefazolinnActivity:nMSSA,StreptococcusnE.c

15、oli,K.pneumoniae,P.mirabilisnIneffective:nEnterococcus,anaerobesnOther GN bacteriaSecond-generation cephemsnTrue cephems:nCefotiam,cefuroxime,cefaclornEnhance the anti-GNB effect of 1st cephemsnLess effective for GPCnCephamycins:nCefmetazole,cefoxitinnWith the effect for anaerobesnIneffective:nMRSA,

16、Enterococcus,other GNBThird-generation cephems(1)nTrue cephem:ncefotaxime,ceftriaxone,ceftazidimenCephamycin:flomoxefnActivity:nAround 50%for MSSAnEnhanced activity for streptococcusnStrong effect for EnterobactereaceanCeftazidime and cefoperazone are also effective for P.aeruginosaThird-generation

17、cephems(2)nFlumarin(flomoxef)nEffective for anaerobes and most MSSAnIneffective:nMRSA,EnterococcusnMore resistant Enterobactereacea,such as Enterobacter,Citrobacter,Serratia,Morganella(若為有效,應combine aminoglycosides)Fourth-generation cephemsnCefepime,cefpiromenActivity:nMost MSSA,StreptococcusnMost e

18、nterobactereacea,including Enterobacter,Citrobacter,Serratia,MorganellanPseudomonas aeruginosanIneffective:nEnterococcus,MRSAnAnaerobes 1 2 2 3 3(+)cephem cephalosporin cephamycin cephem cephemGram(+)Staph MSSA +-MRSA -Streptococcus +Enterococcus -Gram(-)E.coli,Kleb -+Enterobacter -+Pseudomonas -+Ha

19、emophilus -+Anaerobic Bacteroides -+-MonobactamnOnly one drug:aztreonamnActivity:nMost GNB,including P.aeruginosanIneffective:nGP bacteria,anaerobesnSpecial consideration:nlactam allergy&impairing renal functionCarbapenemsnImipenem&meropenemnActivity:nAlmost all bacteria are susceptiblenIneffective:

20、nMRSA,Enterococcus faceium,Burkholderia cepaciae,Stenotrophomonas maltophilianSpecial consideration:nMeropenem is preferred in CNS infectionMonobactamCarbapenemGram(+)Staph MSSA -+MRSA -Streptococcus -+Enterococcus -+Gram(-)E.coli,Kleb +Enterobacter +Pseudomonas +Haemophilus +Anaerobic Bacteroides -

21、+Exception:(1)MRSA(2)Enterococcus faecium(3)Stenotrophomonas maltophilia(4)Burkholderia cepaciaMonobactam(Aztreonam);Carbapenem(Imipenem+Cilastatin sodium;Meropenem)Classification of QuinolonesnFirst generationnNalidixic acidnOxolinic acidnCinoxacinnSecond generationnNorfloxacinnCiprofloxacinnEnoxac

22、innLomefloxacinnOfloxacinnThird generationnLevofloxacinnSparfloxacinnGatifloxacinnGrepafloxacinnFourth generationnTrovafloxacinnMoxifloxacinFluoroquinolonesnActivity:nMSSA,some enterococcus,most GNB(salmonella&shigella)mycobacterium,clamydia,mycoplasma,legionella,dipheria,pertusisn3rd-generation hav

23、e the effect for streptococcus,anaerobesnIneffective:MRSAFluoroquinolonesnSpecial consideration:nOne step mutation results in resistancenCross resistance is a common phenomenonnCiprofloxacin is not effective for streptococcus in vivonSignificant hepatotoxicity:trovafloxacin,grepafloxacinnSignificant

24、 photosensitivity:sparfloxacin,clinafloxacinnSignificant cardiac adverse effect:grepafloxacin(QTc)nSignificant CNS excitatory effect:clinafloxacinFluoroquinolonePathogen GNB NFGNB GPC Atypical Anaerobic1st generation Pipemidic acid(Dolcol)+-2nd generation Ciprofloaxin(Cirpoxin)+-+-Norfloxacin(Baccid

25、al)3rd generation Levofloxacin(Cravit)+/-Moxifloxacin(Avelox)Gatifloxacin4th generation Trovafloxacin +SparfloxacinAminoglycosidesnStreptomycinnKanamycinnGentamicinnTobramycinnNetilmicinnAmikacinnAnti-Gram-negative bacterianCould be used alone,but seldom used alonenIn combination with other antibiot

26、icsn-lactam+aminoglycosideAminoglycosidesnDrugs:nGentamicin,tobramycin,amikacinnActivity:nMost bacterianIneffective:H.influenzae&anaerobesnSpecial consideration:nNot active in anaerobic and acidic areanOnce daily regimennSynergism with lactamsAminoglycosidesnAnti-Gram-positive bacterianHas anti-Gram

27、-positive activity,but never used alone for Gram-positive infectionnIn combination with other antibioticsnInfective endocarditisnPenicillin G+gentamicinnEnterococcus infectionnAmpicillin+gentamicinnStaphylococcus infectionnOxacillin+gentamicinnVancomycin+gentamicinAminoglycosidesnThe only bactericid

28、al agent among protein synthesis inhibitorsnAlways used in combination therapy:nWith-lactam and glycopeptides:the best synergistic effectsnWith clindamycin and metronidazole for mixed infectionsnWith quinolones:additive?antagonism?synergism?nNot penetrating BBBnImportant indications:nSevere aerobic

29、Gm(-)bacilli bacteremianFor treatment of Pseudomonas,Enterobacter,Serratia,Enterococcus,Streptococcal endocarditisnEmergence of resistance during therapy is rareAnti-Gram-Positive AntibioticsnGlycopeptides(Vancomycin,Teicoplanin)nMainly anti-Gram-positive activitynStreptogramins(Quinupristin/dalfopr

30、istin,Synercid)nAntibiotic-resistant GPC,esp.VRE,MRSA,VISA,and antibiotics-resistant strains of S.pneumoniae nOxazolidinones(Linezolid,Zyvox)nAerobic andanaerobic GP bacteria,including VRE,MRSA,antibiotics-resistant strains of S.pneumoniae GlycopeptidesnVancomycin,teicoplaninnActivity:nMost GP bacte

31、ria,including anaerobesnIn vitro,effective for Chryseobacterium meningosepticumnIneffective:nAlmost all GN bacterianGP bacteria only:nLeukonostoc and PediococcusGlycopeptidesnVancomycin compared with teicoplanin:nGenerally,recognized as the same effectnBenefits:nSerum level as the guide of dosagenCo

32、uld combined with rifampinnShortage:nShould be infused at 500 mg/hour with large amount of fluid-red man syndromenRenal toxicity and ototoxicitynIneffective for Van B phenotype VRENew anti-GP AntibioticsnNew anti-GP antibiotics:nFusidic acidnQuinupristin/dalfopristin(Synercid)nOxazolidinones:eperezo

33、lid,linezolid(Zyvox)nActivity:nAlmost all GP bacteria,including MRSAnSynercid and Zyvox are also effective for VREnFusidic acid is also effective for H.influenzae and M.catarrhalisMarcolidesnErythromycinnRoxithromycinnClarithromycinnAzithromycinNew marcolidesNew marcolides v.s.ErythromycinnSimilar a

34、ntibacterial activitynBetter pharmacokineticsnLonger half life(qd or bid)nHigher intracellular concentrationnLess side effect,especially GI side effectMacrolidesn“Old”macrolides:erythromycinn“New”macrolides:nClarithromycin,roxithromycin,azithromycinnActivity:nGPC:MSSA&S.pneumoniae(not in Taiwan)nB.p

35、ertusis,C.diphtheria,L.pneumophila,M.pneumoniae,syphilis,Chlamydia,U.urealyticum,Campylobacter,Helicobacter,NTM.MarcolidesnAnti-Gram-positive activityStaphylococcusStreptococcusMSSAMRSAPneumoGroup AR:3050%80%90%30%nAnti-atypical-pathogensnMycoplasmanLegionellanChlamydiaFluoroquinoloneVancomycinMarco

36、lideGram(+)Staph MSSA +-+MRSA -+-+Streptococcus +-+Enterococcus +-+Gram(-)E.coli,Kleb +-Enterobacter +-Pseudomonas +-Haemophilus +-Anaerobic Bacteroides -Sulfa drugsnSulfamethoxazole+Trimethoprim(Co-trimoxazole)(Baktar,Septrim)nClinical applicationsnSimple UTInPneumocystis carinii infectionnTraveler

37、 diarrheanSalmonellosisnSuppression therapy of MRSA infectionsnPneumocystis carinii infectionsnToxoplasmosisnInflammatory bowel diseasesTetracyclinesnTetracycline,Minocycline,Doxycycline q6h q12h q24hnIndicationsnMycoplasma infectionnChlamydia infectionnRickettsial infectionnScrub typhus(Tsutsugamus

38、hi disease)nQ fevernDrug of choice for CAP(not in Taiwan)nRickettsial infectionsnEffective for Vibrio spp.Metronidazole,Chloramphenicol,ClindamycinnAnti-anaerobic drug(cephamycin,-lactam+-lactamase inhibitor,carbapenem,metronidazole,clindamycin)nMetronidazolenAmeba,Trichomonas infectionnPseudomembra

39、ne colitis(Clostridium difficile)nClindamycinnAnti-Gram-positive alternative agentOther AntibioticsnClindamycin:nMSSA,some CNS,Gr.A Streptococcus,GP anaerobesnWell-penetration to bonenMetronidazole:nGN anaerobes,C.difficile (Pseudomembrane colitis)nAmeba and some other parasitesnChloramphenicol:bone

40、 marrow suppressionDrug of choiceAlternative(1)Alternative(2)Gram(+)Staph MSSAOxacillin1 cephem Vancomycin MRSAVancomycinTeicoplaninStreptococcusPenicillin GCephalosporinVancomycinEnterococcusAmpicillin,Pc GVancomycinGram(-)E.coli,KlebCephalosporin-lactamase inhibitorFluoroquinoloneEnterobacter?PseudomonasExtended Pc,3 cephemMonobactamFluoroquinoloneHaemophilusAmpicillin-lactamase inhibitor2 cephemAnaerobic BacteroidesMetronidazole,clindamycin-lactamase inhibitorCephamycin

侵权处理QQ:3464097650--上传资料QQ:3464097650

【声明】本站为“文档C2C交易模式”,即用户上传的文档直接卖给(下载)用户,本站只是网络空间服务平台,本站所有原创文档下载所得归上传人所有,如您发现上传作品侵犯了您的版权,请立刻联系我们并提供证据,我们将在3个工作日内予以改正。


163文库-Www.163Wenku.Com |网站地图|